CD8A and neoplasm: The in vivo anti-tumor effect was likely dependent on both CD4(+) T cells and CD8(+) T cells, as our serial IHC data (Fig. 1d) did suggest a temporal sequence where the initial arrival of CD4(+) T cells was followed by subsequent infiltration of CD8(+) T cells.